Maravai Lifesciences Holdings (MRVI) EPS (Basic) (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly EPS (Basic) came in at -$0.04 in Q1 2026, up 88.18% year-on-year from -$0.02 in Q1 2025, and up 90.02% quarter-over-quarter from -$0.44 in Q4 2025.
Maravai Lifesciences Holdings (MRVI) EPS (Basic) (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.04 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 88.18% year-over-year to -$0.04 in Q1 2026; TTM through Mar 2026 was -$1.26, a 37.71% increase from a year earlier, with the FY2025 full-year figure at -$1.6, up 15.09% from the prior year.
- EPS (Basic) grew to -$0.04 in Q1 2026 per MRVI's latest filing, from -$0.44 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.19 in Q2 2022 and bottomed at -$1.22 in Q3 2024.
- The 5-year median for EPS (Basic) is -$0.14 (2024), against an average of -$0.05.
- Across the five-year window, EPS (Basic) sank 1574.94% in 2024 and soared 88.18% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at $0.66 in 2022, then plunged by 225.44% to -$0.83 in 2023, then soared by 59.93% to -$0.33 in 2024, then plunged by 30.67% to -$0.44 in 2025, then surged by 90.02% to -$0.04 in 2026.
- Per Business Quant, the three latest MRVI EPS (Basic) figures stand at -$0.04 (Q1 2026), -$0.44 (Q4 2025), and -$0.31 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.44 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.48 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | -0.33 |
| Sep 30, 2024 | -1.22 |
| Jun 30, 2024 | -0.14 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.83 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | 0.66 |
| Sep 30, 2022 | 0.76 |
| Jun 30, 2022 | 1.19 |
| Mar 31, 2022 | 1.12 |
| Dec 31, 2021 | 1.11 |
| Sep 30, 2021 | 1.12 |
| Jun 30, 2021 | 1.20 |